Aclaris Therapeutics ACRS
NASDAQ ACRS
$3.90 +0.13 (+3.45%)
As of: Oct 21, 2026 · 11:22 AM EDT

Aclaris Therapeutics (ACRS) Total Non-Current Liabilities (2014 - 2026)

Updated

Aclaris Therapeutics (ACRS) recorded Total Non-Current Liabilities of $43.81 million in Q2 2026, down 6.6% from $46.91 million a year earlier and down 0.6% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Aclaris Therapeutics reported Total Non-Current Liabilities of $46.38 million, down 17.3% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $56.07 million in FY2024 (+64.8%), $34.03 million in FY2023 (+42.5%), $23.88 million in FY2022 (-6.3%) and $25.47 million in FY2021 (-12.4%).
  • The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q3 2024.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 42.9% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 159.9% in Q2 2025, against a decline of 36.3% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $44.07 million (Q1 2026), $46.38 million (Q4 2025) and $44.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 106.45 Bn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 33.91 Bn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 97.04 Bn
10 Aclaris Therapeutics 554.53 Mn 170.90 Mn 1.41 Mn 42.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.55 Mn
Mar 31, 2026 42.66 Mn
Dec 31, 2025 44.81 Mn
Sep 30, 2025 43.12 Mn
Jun 30, 2025 45.06 Mn
Mar 31, 2025 40.72 Mn
Dec 31, 2024 51.63 Mn
Sep 30, 2024 40.00 Mn
Jun 30, 2024 15.68 Mn
Mar 31, 2024 20.08 Mn
Dec 31, 2023 30.95 Mn
Sep 30, 2023 27.69 Mn
Jun 30, 2023 23.20 Mn
Mar 31, 2023 18.63 Mn
Dec 31, 2022 22.31 Mn
Sep 30, 2022 20.16 Mn
Jun 30, 2022 16.58 Mn
Mar 31, 2022 17.09 Mn
Dec 31, 2021 23.30 Mn
Sep 30, 2021 18.21 Mn
API Access

Aclaris Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ACRS&period=max&api_key=YOUR_API_KEY